Development of new heart failure therapeutics by analysing signalling in heart failure as a network

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1053089

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

After detailed analysis of cell signalling in diseased heart tissue we will facilitate the discovery of new therapeutic drug targets to stop the progression of heart failure in its early stages. It is hoped that the detailed analysis of heart failure signalling as a network rather than as individual pathways will enable the discovery of drugs which are more successful in stopping the progression of heart failure than the currently available drugs.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2017

Funding Scheme: Early Career Fellowships

Funding Amount: $314,965.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Biotechnology not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiac failure | cardiac hypertrophy | heart development | pharmacology | tissue engineering

Related Links